Literature DB >> 2783958

Abnormal proteolysis (DIC)--successful treatment with antithrombin III concentrate and a concentrate containing F XIII and native von Willebrand factor.

M Delshammar1, A Lasson, I M Nilsson, K Ohlsson, A Wallmark, E Vernersson.   

Abstract

Two patients with life-threatening disseminated intravascular coagulation (DIC) syndrome, one caused by Gram-negative bacteria and one by premature separation of the placenta, are described. Specific substitution was given by antithrombin III concentrate and AHF-Kabi, a low purity factor VIII concentrate containing native von Willebrand factor and factor XIII. The treatment quickly returned the extremely low levels of antithrombin III, factor VIII:C, fibrinogen and factor XIII, initially found, to normal, and also returned the multimeric pattern of von Willebrand factor to normal. This resulted in diminished bleeding, enabling surgical treatment of the underlying disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783958     DOI: 10.1111/j.1365-2796.1989.tb00031.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  1 in total

1.  Plasma factor XIII activity in patients with disseminated intravascular coagulation.

Authors:  Jae Woo Song; Jong Rak Choi; Kyung Soon Song; Ji-Hyuk Rhee
Journal:  Yonsei Med J       Date:  2006-04-30       Impact factor: 2.759

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.